Cushing's syndrome induced by betamethasone nose drops. In rhinological disease betamethasone should be regarded as systemic corticosteroid.
作者信息
Homer J J, Gazis T G
出版信息
BMJ. 1999 May 15;318(7194):1355.
Abstract
摘要
相似文献
1
2
3
Cushing's syndrome induced by betamethasone nose drops. Learning difficulties may complicate the issue.
BMJ. 1999 May 15;318(7194):1356.
4
Childhood Cushing's syndrome induced by betamethasone nose drops, and repeat prescriptions.
BMJ. 1998 Sep 12;317(7160):739-40. doi: 10.1136/bmj.317.7160.739.
5
Iatrogenic Cushing's syndrome in a dog from owner's topical corticosteroid.
Arch Dermatol. 1993 Mar;129(3):379. doi: 10.1001/archderm.1993.01680240125022.
6
Iatrogenic Cushing's syndrome.
Indian Pediatr. 1998 Dec;35(12):1236-7.
7
Iatrogenic Cushing's syndrome: a different story.
Lancet. 2003 Mar 22;361(9362):1059. doi: 10.1016/S0140-6736(03)12811-5.
8
Cushing syndrome following the prescription of antifungal, antibiotic, corticosteroid cream.
Int J Dermatol. 2003 Apr;42(4):318. doi: 10.1046/j.1365-4362.2003.01799_1.x.
9
Cushing's syndrome due to the abuse of betamethasone nasal drops.
J Laryngol Otol. 1988 Mar;102(3):219-21. doi: 10.1017/s0022215100104566.
10
Iatrogenic Cushing's syndrome in children following nasal steroid.
Pan Afr Med J. 2014 Mar 28;17:237. doi: 10.11604/pamj.2014.17.237.3332. eCollection 2014.
引用本文的文献
1
Iatrogenic Cushing's syndrome as a consequence of nasal use of Betamethasone spray during pregnancy.
Acta Endocrinol (Buchar). 2020 Oct-Dec;16(4):511-517. doi: 10.4183/aeb.2020.511.
2
Iatrogenic Cushing syndrome caused by ocular glucocorticoids in a child.
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.11.2008.1224. Epub 2009 May 8.
3
BSACI guidelines for the management of allergic and non-allergic rhinitis.
Clin Exp Allergy. 2008 Jan;38(1):19-42. doi: 10.1111/j.1365-2222.2007.02888.x.
4
Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.
Drug Saf. 2003;26(12):863-93. doi: 10.2165/00002018-200326120-00003.
5
Comparison of medical and surgical treatment of nasal polyposis.
Curr Allergy Asthma Rep. 2002 Nov;2(6):494-9. doi: 10.1007/s11882-002-0090-2.
本文引用的文献
1
The effect of six weeks topical nasal betamethasone drops on the hypothalamo-pituitary-adrenal axis and bone turnover in patients with nasal polyposis.
Clin Otolaryngol Allied Sci. 1999 Dec;24(6):495-8. doi: 10.1046/j.1365-2273.1999.00299.x.
2
Childhood Cushing's syndrome induced by betamethasone nose drops, and repeat prescriptions.
BMJ. 1998 Sep 12;317(7160):739-40. doi: 10.1136/bmj.317.7160.739.
3
Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids.
Thorax. 1997 May;52(5):476-82. doi: 10.1136/thx.52.5.476.
4
Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids.
Acta Paediatr. 1993 Aug;82(8):635-40. doi: 10.1111/j.1651-2227.1993.tb18030.x.
5
Down's syndrome: a modern otorhinolaryngological perspective.
Laryngoscope. 1981 Oct;91(10):1581-94. doi: 10.1288/00005537-198110000-00001.
6
Intranasal drug delivery by spray and drops.
J Pharm Pharmacol. 1985 May;37(5):294-7. doi: 10.1111/j.2042-7158.1985.tb05069.x.
7
Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test.
J Clin Endocrinol Metab. 1991 Apr;72(4):773-8. doi: 10.1210/jcem-72-4-773.
8
Doctors and drops.
BMJ. 1991 Sep 28;303(6805):761. doi: 10.1136/bmj.303.6805.761.
Zotero 插件